Showing results (131-140 of 193) with videos related to
Sort By:
Pageof 20
Journal of Personalized Medicine|December 23, 2022
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast StudyChrystel Isca, Amelia Spinella, Angela Toss, et al.Cancer Discovery|May 16, 2024
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer EvolutionIros Barozzi, Neil Slaven, Eleonora Canale, et al.Plos Genetics|January 3, 2023
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, et al.Blood|January 12, 2022
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALLMateusz Antoszewski, Nadine Fournier, Gustavo A Ruiz Buendía, et al.Science Translational Medicine|June 30, 2017
Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphomaElisa Oricchio, Natalya Katanayeva, Maria Christine Donaldson, et al.ACS Nanoscience Au|October 20, 2025
Delivery of Biomolecules into Individual Cells and Subcellular Compartments by Localized Electroporation via NanopipetteFabio Marcuccio, Philip S Goff, Devkee M Vadukul, et al.Nature Communications|December 9, 2025
Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbationSabrina Pia Nuccio, Enrico Cadoni, Roxani Nikoloudaki, et al.Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.Nature Communications|August 21, 2019
Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancerYlenia Perone, Aaron J Farrugia, Alba Rodríguez-Meira, et al.Nature Communications|April 23, 2020
Exploiting evolutionary steering to induce collateral drug sensitivity in cancerAhmet Acar, Daniel Nichol, Javier Fernandez-Mateos, et al.Pageof 20